Harvard and MIT team engineer LBP to protect gut from antibiotic dysbiosis 22-Apr-2022 By Will Chu Harvard and MIT researchers have suggested an engineered live biotherapeutic (eLBP) may protect the gut microbiome against antibiotic-induced dysbiosis.